|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Glucocortieoid therapy and diabetes management显示文摘 | Volgi JR Baldwin D Jr | 2001 | Nuts Clin North Am2001，36，： | 1 |
| 2 | Rationale for and study design of the sulodexide trials in Type 2 diabetic, hyper- tensive patients with microalbuminuria or overt nephropathy显示文摘 | LAMBERS HJ FOWLER M J VOLGI J | 2007 | Diabetic Med2007，24，： | 1 |
| 3 | Ralionale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy 显示文摘 | Lambers-Heerspink H J Fowler M J Volgi J | 2007 | Diabet Med2007，24，11： | 1 |
| 4 | Rationale for and study design of the sulodexide trials in type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy显示文摘 | Lambers HJ Fowler M J Volgi J | 2007 | Diabet Med2007，11，24： | 1 |
| 5 | Rationale for and study design of the sulodexide trials in type 2 diabetic,hypertensive patients with urinary albumin excretion rate or overt nephropathy显示文摘 | Lambers Heerspink HJ Fowler MJ Volgi J | 2007 | Diabet Med2007，24，11： | 1 |
| 6 | Rationale for and study design of the sulodexide trials in Type 2 diabetic,hypertensive patients with urinary albumin excretion rate or overt nephropathy显示文摘 | Lambers Heerspink HJ Fowler MJ Volgi J | 2007 | Diabet Med2007，11，24： | 1 |
| 7 | Rationale for and study design of the sulodexide trials in type 2 diabetic,hypertensive patients with urinary albumin excretion rate or overt nephmpathy显示文摘 | Lambers Heerspink H J Fowler M J Volgi J | 2007 | Diabet Med2007，24，11： | 1 |
| 8 | Glucocorticoid therapy and diabetes management显示文摘 | Volgi JR Baldwin D Jr | 2001 | Nurs Clin North Am2001，36，2： | 1 |
| 9 | Rationale for and study design of the sulodexide trials in type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy显示文摘 | Lambers HH Fowler MJ Volgi J | 2007 | Diabet Med2007，24，11： | 1 |
| 10 | Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy 显示文摘 | Lambers H J Fowler M J Volgi J | 2007 | Diabetic Med2007，24，： | 1 |
| 11 | Glucocorticoid therapy and diabetes management显示文摘 | Volgi JR Baldwin D Jr | 2001 | Nurs Clin North Am2001，36，2： | 1 |
| 12 | Glueocorticoid therapy and diabetes man-agement显示文摘 | Volgi JR Baldwin D Jr | 2001 | Nurs Clin Noah Am2001，36，2： | 1 |
| 13 | Rationale for and study design of the sulodexide trials in type 2 dia- betic, hypertensive patients with microalbuminuria or overt ne- phropathy显示文摘 | LAMBERS HEERSPINK H J FOWLER M J VOLGI J | 2007 | Diabetic Med2007，24，11： | 1 |
| 14 | Rationale for and study design of the sulodexide trials in type 2 diabetic,hypertensive patients wit microalbuminuria or overt nephropathy显示文摘 | Lambers HJ Fowler MJ Volgi J | | 0，，： | 1 |
| 15 | Glucocorticoid therapy and Diabetes management显示文摘 | Volgi JR Baldwin D | 2001 | Nurs Clin Am2001，36，2： | 1 |
| 16 | Rationale for and study design of the sulodexide trials in Type 2 diabetic,hypertensive patients microalbuminuria or overt nephropathy显示文摘 | Lambers Heerspink HJ Fowler MJ Volgi J | | 0，，24： | 1 |
| 17 | Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy显示文摘 | Lambers Heerspink HJ Fowler MJ Volgi J | 2007 | Diabet Med2007，24，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员